“Enhanced Antitumor Efficacy of Gemcitabine through Dual-Responsive Nanoparticle-Mediated Therapy in Pancreatic Cancer”, J. Can. Res. Updates, vol. 15, no. 3, pp. 186–196, Jul. 2026, doi: 10.30683/1929-2279.2026.15.17.